Search research articles
Contact Us
Filters
Showing results (411-420 of 488) with videos related to
Page
of 49
Sort By:
Archives of Dermatology
|
April 1, 1987
Cholinergic urticaria. A clinical and histologic study
J V Hirschmann, F Lawlor, J S English, et al.
Clinical and Experimental Immunology
|
March 1, 1987
Release in vivo of IL-1 like activity by human skin
P M Dowd, B N Hudspith, J A Miller, et al.
The Journal of Investigative Dermatology
|
July 1, 1990
Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis
A K Black, R D Camp, A I Mallet, et al.
Archives of Dermatological Research
|
January 1, 1994
Platelet activating factor (PAF) and lyso-PAF in psoriasis
M R Judge, R M Barr, A I Mallet, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
January 5, 2002
Definition, classification, and routine diagnosis of urticaria: a consensus report
T Zuberbier, M W Greaves, L Juhlin, et al.
Pain Medicine (Malden, Mass.)
|
December 28, 2016
Development and Preliminary Evaluation of an Integrated Cognitive-Behavior Treatment for Chronic Pain and Substance Use Disorder in Patients with the Hepatitis C Virus
Benjamin J Morasco, David W Greaves, Travis I Lovejoy, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1987
Modulation of cutaneous interleukin-1 (IL-1)-like activity by endogenously produced eicosanoids
P M Dowd, R M Barr, B N Hudspith, et al.
Clinical and Experimental Rheumatology
|
March 1, 1995
Antiendothelial cell antibodies in chronic urticaria
C E Grattan, D P D'Cruz, D M Francis, et al.
British Journal of Clinical Pharmacology
|
October 1, 1984
The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin
E Wong, R M Barr, S D Brain, et al.
British Journal of Clinical Pharmacology
|
February 1, 1980
Elevated blood histamine levels and mast cell degranulation in solar urticaria
J L Hawk, R A Eady, A V Challoner, et al.
Page
of 49
Search research articles
Search
Showing results (411-420 of 488) with videos related to
Sort By:
Page
of 49
Archives of Dermatology
|
April 1, 1987
Cholinergic urticaria. A clinical and histologic study
J V Hirschmann, F Lawlor, J S English, et al.
Clinical and Experimental Immunology
|
March 1, 1987
Release in vivo of IL-1 like activity by human skin
P M Dowd, B N Hudspith, J A Miller, et al.
The Journal of Investigative Dermatology
|
July 1, 1990
Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis
A K Black, R D Camp, A I Mallet, et al.
Archives of Dermatological Research
|
January 1, 1994
Platelet activating factor (PAF) and lyso-PAF in psoriasis
M R Judge, R M Barr, A I Mallet, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
January 5, 2002
Definition, classification, and routine diagnosis of urticaria: a consensus report
T Zuberbier, M W Greaves, L Juhlin, et al.
Pain Medicine (Malden, Mass.)
|
December 28, 2016
Development and Preliminary Evaluation of an Integrated Cognitive-Behavior Treatment for Chronic Pain and Substance Use Disorder in Patients with the Hepatitis C Virus
Benjamin J Morasco, David W Greaves, Travis I Lovejoy, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1987
Modulation of cutaneous interleukin-1 (IL-1)-like activity by endogenously produced eicosanoids
P M Dowd, R M Barr, B N Hudspith, et al.
Clinical and Experimental Rheumatology
|
March 1, 1995
Antiendothelial cell antibodies in chronic urticaria
C E Grattan, D P D'Cruz, D M Francis, et al.
British Journal of Clinical Pharmacology
|
October 1, 1984
The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin
E Wong, R M Barr, S D Brain, et al.
British Journal of Clinical Pharmacology
|
February 1, 1980
Elevated blood histamine levels and mast cell degranulation in solar urticaria
J L Hawk, R A Eady, A V Challoner, et al.
Page
of 49